Search results for "severity"

showing 10 items of 1287 documents

Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST tria…

2010

Introduction: Systolic hypertension is very common in the elderly and is strongly associated with the risk of cardiovascular and cerebrovascular events. The control of systolic hypertension is difficult and most patients require combination antihypertensive therapy. Few data are available regarding the efficacy of angiotensin II receptor antagonists on systolic hypertension of the elderly. The aim of this double-blind, double-dummy, randomized, parallel-group, multicenter study was to assess the efficacy of eprosartan 600 mg in combination with hydrochlorothiazide (HCTZ)12.5 mg in comparison with losartan 50 mg in combination with HCTZ 12.5 mg, in reducing blood pressure in elderly patients…

MaleSystolic hypertensionOffice VisitsPharmacologySeverity of Illness Indexlaw.inventionHydrochlorothiazideRandomized controlled triallawAngiotensin II Type 1 Receptor BlockerPharmacology (medical)DiureticsImidazolesGeneral MedicineBlood Pressure Monitoring AmbulatoryAntihypertensive AgentLosartanHydrochlorothiazideTreatment OutcomeAcrylatesHypertensionCardiologyDrug Therapy CombinationFemaleDrug MonitoringHumanmedicine.drugmedicine.medical_specialtyAmbulatory blood pressureSystoleLosartan/hydrochlorothiazideThiopheneselderly patientselderlyLosartanStatistics NonparametricDouble-Blind MethodThiopheneInternal medicinemedicineDiureticHumansImidazoleAntihypertensive AgentsAgedAnalysis of Variancebusiness.industryeprosartanEprosartanmedicine.diseaseambulatory blood pressure monitoringAcrylateBlood pressureOffice VisitbusinessAngiotensin II Type 1 Receptor BlockersAdvances in therapy
researchProduct

Leisure-Time physical activity, sedentary behaviour and diet quality are associated with metabolic syndrome severity: the PREDIMED-Plus Study

2020

The authors especially thank the PREDIMED-Plus participants for their enthusiastic collaboration, the PREDIMED-Plus personnel for outstanding support, and the personnel of all associated primary care centres for their exceptional effort. CIBEROBN, CIBERESP and CIBERDEM are initiatives of Instituto de Salud Carlos III, Spain. We thank the PREDIMED-Plus Biobank Network, part of the National Biobank Platform of Instituto de Salud Carlos III for storing and managing biological samples.

MaleSíndrome metabòlicaMediterranean diethumanosejercicio físico030204 cardiovascular system & hematologyOverweightSeverity of Illness Indexlaw.inventionchemistry.chemical_compound0302 clinical medicineSedentarismeRandomized controlled triallaw030212 general & internal medicineDepression (differential diagnoses)mediana edad2. Zero hungerMetabolic SyndromeancianoNutrition and Dietetics4. EducationMiddle Aged16. Peace & justiceMetabolic syndrome3. Good healthFemalemedicine.symptomlcsh:Nutrition. Foods and food supplymedicine.medical_specialtylcsh:TX341-641Article03 medical and health sciencesFood PreferencesMediterranean cookingLeisure ActivitiesInternal medicineMediterranean dietCuina mediterràniamedicineingesta energéticaHumansíndice de gravedad de la enfermedadExerciseMetabolic syndrome severityAgedbusiness.industryCholesterolPhysical activityactividades de ocioSedentary behaviourAnthropometryPhysical fitnessmedicine.diseaseObesitypreferencias alimenticiasSedentary behaviorCross-Sectional StudieschemistryDepression riskMetabolic syndromeSedentary BehaviorbusinessEnergy IntakeFood Scienceestudios transversalesCondició física
researchProduct

Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome

2008

Abstract Background and aim Diabetes mellitus increases the risk of stroke, and pathophysiological changes of diabetic cerebral vessels may differ in comparison with non-diabetic ones; nonetheless, the clinical and prognostic profile of stroke in diabetic patients is not yet fully understood. On this basis, the aim of our study was to evaluate cerebrovascular risk factor prevalence in diabetic stroke patients in comparison with non-diabetics, to analyze whether diabetics have a different prevalence of stroke subtypes as classified by the TOAST classification, and determine whether diabetics and non-diabetics have a different prognosis. Methods and results We enrolled 102 diabetics and 204 n…

MaleTOAST ClassificationTime FactorsSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Severity of Illness IndexBrain IschemiaRecurrenceRisk FactorsOdds RatioPrevalenceMedicineStrokeAged 80 and overNutrition and Dieteticsdiabetes mellituMiddle AgedPrognosisStrokeAcute DiseaseHypertensionCardiologyFemaleSettore MED/26 - NeurologiaCardiology and Cardiovascular Medicinemedicine.medical_specialtyLacunar strokeRisk AssessmentDiabetes ComplicationsTOAST classificationDiabetes mellitusInternal medicineSeverity of illnessischemic strokeHumanscardiovascular diseasesAgedbusiness.industryCase-control studyRecovery of FunctionOdds ratiomedicine.diseaseSSS*Logistic ModelsDiabetes Mellitus Type 2Case-Control StudiesPhysical therapyScandinavian Stroke ScalebusinessFollow-Up Studies
researchProduct

Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke

2009

Few studies have examined the relationship between inflammatory biomarker blood levels, cardioembolic stroke subtype and neurological deficit. So the aim of our study is to evaluate plasma levels of immuno-inflammatory variables in patients with cardio-embolic acute ischaemic stroke compared to other diagnostic subtypes and to evaluate the relationship between immuno-inflammatory variables, acute neurological deficit and brain infarct volume. One hundred twenty patients with acute ischaemic stroke and 123 controls without a diagnosis of acute ischaemic stroke were evaluated. The type of acute ischaemic stroke was classified according to the TOAST classification. We evaluated plasma levels o…

MaleTOAST Classificationmedicine.medical_specialtySettore MED/09 - Medicina InternaHeart DiseasesEmbolismInterleukin-1betaSeverity of Illness IndexBrain Ischemiacytokines stroke cardioembolicCentral nervous system diseaseBrain ischemiaDisability EvaluationPredictive Value of TestsInternal medicineSeverity of illnessmedicineHumanscardiovascular diseasesStrokeAgedAged 80 and overInterleukin-6Tumor Necrosis Factor-alphaVascular diseasebusiness.industryCerebral infarctionCase-control studyHematologyMiddle Agedmedicine.diseaseSurgeryStrokeRisk Factors inflammation cytokines Stroke Cerebral infarct cerebrovascular disease cerebrovascular accidentCase-Control StudiesLinear ModelsCardiologyFemaleSettore MED/26 - NeurologiaInflammation MediatorsbusinessBiomarkers
researchProduct

Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity in…

2015

Abstract Background Adherence to a Mediterranean Diet appears to reduce the risk of cardiovascular disease, cancer, Alzheimer's disease, and Parkinson's disease, as well as the risk of death due to cardiovascular disease. No study has addressed the association between diagnostic subtype of stroke and its severity and adherence to a Mediterranean Diet in subjects with acute ischemic stroke. Aim To evaluate the association between Mediterranean Diet adherence, TOAST subtype, and stroke severity by means of a retrospective study. Methods The type of acute ischemic stroke was classified according to the TOAST criteria. All patients admitted to our ward with acute ischemic stroke completed a 137…

MaleTOAST subtypemedicine.medical_specialtySettore MED/09 - Medicina InternaMediterranean dietPopulationDiseaseDiet MediterraneanSeverity of Illness IndexBrain IschemiaBrain ischemiaMediterranean Diet scoreRisk FactorsSurveys and QuestionnairesInternal medicineSeverity of illnessmedicineHumanscardiovascular diseaseseducationStrokeAgedRetrospective Studieseducation.field_of_studyMediterranean Dietbusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseStrokeSSS*Cardiovascular DiseasesPhysical therapyPatient ComplianceRegression AnalysisFemaleCardiology and Cardiovascular MedicinebusinessAtherosclerosis
researchProduct

Relevance of supraventricular runs detected after cerebral ischemia

2017

Objective:Prolonged ECG monitoring after stroke frequently reveals short paroxysmal atrial fibrillation (pAF) and supraventricular (SV) runs. The minimal duration of atrial fibrillation (AF) required to induce cardioembolism, the relevance of SV runs, and whether short pAF results from cerebral damage itself are currently being debated. We aimed to study the relevance of SV runs and short pAF detected by prolonged Holter ECG after cerebral ischemia during long-term follow-up.Methods:Analysis is from the prospective Find-AF trial (ISRCTN46104198). We included patients with acute cerebral ischemia. Those without AF on admission received 7-day Holter ECG monitoring. We differentiated patients …

MaleTachycardia Ectopic AtrialTachycardiamedicine.medical_specialtyTime FactorsIschemiaKaplan-Meier Estimate030204 cardiovascular system & hematologySeverity of Illness IndexBrain IschemiaElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationSeverity of illnessmedicineHumansProspective Studiescardiovascular diseasesProspective cohort studyStrokeAgedAged 80 and overmedicine.diagnostic_testbusiness.industryAtrial fibrillationMiddle Agedmedicine.diseaseAmbulatoryElectrocardiography AmbulatoryCardiologyFemaleNeurology (clinical)medicine.symptombusinessElectrocardiography030217 neurology & neurosurgeryFollow-Up StudiesNeurology
researchProduct

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

2016

Tafamidis is a transthyretin (TTR) stabilizer able to prevent TTR tetramer dissociation. There have been a few encouraging studies on Tafamidis efficacy in early-onset inherited transthyretin amyloidosis (ATTR) due to Val30Met mutation. However, less is known about its efficacy in later disease stages and in non-Val30Met mutations. We performed a multi-center observational study on symptomatic ATTR patients prescribed to receive Tafamidis. We followed up patients according to a standardized protocol including general medical, cardiological and neurological assessments at baseline and every 6 months up to 3 years. Sixty-one (42 males) patients were recruited. Only 28 % of enrolled subjects h…

MaleTafamidisAmyloid polyneuropathyNeurologyCardiomyopathyDisease030204 cardiovascular system & hematologySeverity of Illness IndexTransthyretinchemistry.chemical_compound0302 clinical medicinePrealbuminTafamidiLongitudinal StudiesStage (cooking)Aged 80 and overBenzoxazolesbiologyAmyloidosisMiddle Agedamyloid polyneuropathy; tafamidis; transthyretinPrognosisTafamidisSettore MED/26 - NEUROLOGIATreatment OutcomeItalyNeurologyDisease ProgressionFemaleAmyloid polyneuropathy; Tafamidis; Transthyretin; Neurology (clinical); NeurologyAdultmedicine.medical_specialty03 medical and health sciencesInternal medicineSeverity of illnessmedicineHumansAgedAmyloid Neuropathies Familialbusiness.industrynutritional and metabolic diseasesmedicine.diseaseSurgeryTransthyretinchemistryMutationbiology.proteinNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up StudiesJournal of Neurology
researchProduct

Unlocking the limitations: Living with chronic obstructive pulmonary disease and receiving care through telemedicine-A phenomenological study

2017

Aims and objectives To describe the lived experiences of quality of life among a group of patients living with chronic obstructive pulmonary disease who were included in a telemedical intervention after hospitalisation for disease exacerbation. Background Patients with chronic obstructive pulmonary disease have high symptom burden, poor control of symptoms and a need for greater requirements in care. Telemedicine can provide benefits for patients with chronic obstructive pulmonary disease by improving self-management. Design Descriptive phenomenological approach. Methods Ten in-depth interviews were conducted with chronic obstructive pulmonary disease patients participating in a telemedical…

MaleTelemedicinemedicine.medical_specialtyPulmonary diseaseSeverity of Illness IndexInterviews as TopicPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineNursingAdaptation PsychologicalPatient experienceHealth caremedicineHumansDisease Exacerbation030212 general & internal medicineIntensive care medicineGeneral NursingAgedAged 80 and overSelf-managementbusiness.industrySelf-ManagementLived experienceSymptom burdenGeneral MedicineMiddle AgedTelemedicine030228 respiratory systemQuality of LifeFemalebusinessJournal of Clinical Nursing
researchProduct

Algorithm for clinical evaluation and surgical treatment of gynaecomastia.

2006

Algorithm for clinical evaluation and surgical treatment of gynaecomastia. Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Cattedra di Chirurgia Plastica e Ricostruttiva, Università degli Studi di Palermo, Palermo, Italy. adriana.cordova@excite.com Abstract BACKGROUND: Gynaecomastia can be classified on the basis of the main characterising factors, i.e. pathogenesis, histopathology and morphology. The morphological classifications of gynaecomastia currently made often use subjective parameters and qualifying adjectives. In this paper the authors propose a scheme for morphological classification of gynaecomastia which can serve as a guide for choosing th…

MaleThoraxmedicine.medical_specialtyMammaplastymedicine.medical_treatmentDecision MakingSettore MED/19 - Chirurgia PlasticaScarsSeverity of Illness IndexPeriareolarLipectomyPtosisHumansMedicineInframammary foldReduction (orthopedic surgery)Retrospective Studiesbusiness.industryRetrospective cohort studymedicine.diseaseSurgerybody regionsGynecomastiaGynecomastiaSurgerymedicine.symptombusinessAlgorithmsgynecomastia.
researchProduct

Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis

2010

Objectives: We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population. Background: Progression of paroxysmal AF to more sustained forms is frequently seen. However, not all patients will progress to persistent AF. Methods: We included 1,219 patients with paroxysmal AF who participated in the Euro Heart Survey on AF and had a known rhythm status at follow-up. Patients who experienced AF progression after 1 year of follow-up were identified. Results: Progression of AF occurred in 178 (15%) patients. Multivariate analysis showed that heart failure, age, previous transient ischemic attac…

MaleTime FactorPrognosiRisk FactorpredictionMiddle AgedRisk AssessmentSeverity of Illness IndexAtrial FibrillationDisease ProgressionepidemiologyFemaleatrial fibrillation; epidemiology; prediction; prognosis; progression; Aged; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Disease ProgressionprogressionAgedHuman
researchProduct